Global Rare Disease Diagnostics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Rare Disease Diagnostics Market Overview

• 1.1 Product Overview and Scope of Rare Disease Diagnostics
• 1.2 Classification of Rare Disease Diagnostics by Types
  • 1.2.1 Global Rare Disease Diagnostics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Rare Disease Diagnostics Revenue Market Share by Types in 2018
  • 1.2.3 Hematology
  • 1.2.4 Oncology
• 1.3 Global Rare Disease Diagnostics Market by Application
  • 1.3.1 Global Rare Disease Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Laboratories
  • 1.3.3 Diagnostic Laboratories
  • 1.3.4 Genetic Testing Laboratories
  • 1.3.5 Cancer Research Laboratories
  • 1.3.6 Others
• 1.4 Global Rare Disease Diagnostics Market by Regions
  • 1.4.1 Global Rare Disease Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Rare Disease Diagnostics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Rare Disease Diagnostics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Disease Diagnostics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Rare Disease Diagnostics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Disease Diagnostics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Rare Disease Diagnostics (2014-2024)

2 Manufacturers Profiles

• 2.1 Retrophin
  • 2.1.1 Business Overview
  • 2.1.2 Rare Disease Diagnostics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 3billion
  • 2.2.1 Business Overview
  • 2.2.2 Rare Disease Diagnostics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 23andMe
  • 2.3.1 Business Overview
  • 2.3.2 Rare Disease Diagnostics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 QIAGEN
  • 2.4.1 Business Overview
  • 2.4.2 Rare Disease Diagnostics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Illumina
  • 2.5.1 Business Overview
  • 2.5.2 Rare Disease Diagnostics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 PerkinElmer
  • 2.6.1 Business Overview
  • 2.6.2 Rare Disease Diagnostics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Strand Life Sciences
  • 2.7.1 Business Overview
  • 2.7.2 Rare Disease Diagnostics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Rare Disease Diagnostics Market Competition, by Players

• 3.1 Global Rare Disease Diagnostics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Rare Disease Diagnostics Players Market Share
  • 3.2.2 Top 10 Rare Disease Diagnostics Players Market Share
• 3.3 Market Competition Trend

4 Global Rare Disease Diagnostics Market Size by Regions

• 4.1 Global Rare Disease Diagnostics Revenue and Market Share by Regions
• 4.2 North America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 4.5 South America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

5 North America Rare Disease Diagnostics Revenue by Countries

• 5.1 North America Rare Disease Diagnostics Revenue by Countries (2014-2019)
• 5.2 USA Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

6 Europe Rare Disease Diagnostics Revenue by Countries

• 6.1 Europe Rare Disease Diagnostics Revenue by Countries (2014-2019)
• 6.2 Germany Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 6.3 UK Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 6.4 France Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Rare Disease Diagnostics Revenue by Countries

• 7.1 Asia-Pacific Rare Disease Diagnostics Revenue by Countries (2014-2019)
• 7.2 China Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 7.5 India Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

8 South America Rare Disease Diagnostics Revenue by Countries

• 8.1 South America Rare Disease Diagnostics Revenue by Countries (2014-2019)
• 8.2 Brazil Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Rare Disease Diagnostics by Countries

• 9.1 Middle East and Africa Rare Disease Diagnostics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)

10 Global Rare Disease Diagnostics Market Segment by Type

• 10.1 Global Rare Disease Diagnostics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Rare Disease Diagnostics Market Forecast by Type (2019-2024)
• 10.3 Hematology Revenue Growth Rate (2014-2024)
• 10.4 Oncology Revenue Growth Rate (2014-2024)

11 Global Rare Disease Diagnostics Market Segment by Application

• 11.1 Global Rare Disease Diagnostics Revenue Market Share by Application (2014-2019)
• 11.2 Rare Disease Diagnostics Market Forecast by Application (2019-2024)
• 11.3 Hospital Laboratories Revenue Growth (2014-2019)
• 11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
• 11.5 Genetic Testing Laboratories Revenue Growth (2014-2019)
• 11.6 Cancer Research Laboratories Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)

• 12.1 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
• 12.2 Global Rare Disease Diagnostics Market Forecast by Regions (2019-2024)
• 12.3 North America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
• 12.4 Europe Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
• 12.6 South America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Rare Disease Diagnostics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology